Presentation is loading. Please wait.

Presentation is loading. Please wait.

Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and.

Published byMarie-Laure Robillard Modified over 5 years ago

Similar presentations

Presentation on theme: "Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and."— Presentation transcript:

1 Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and B, lysates from H358-TwistER cells before EMT 72 hours after transfection with indicated siRNA oligos, se... Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and B, lysates from H358-TwistER cells before EMT 72 hours after transfection with indicated siRNA oligos, serum-starved overnight. C, immunoprecipitation of indicated proteins from H358-TwistER lysates 72 hours after transfection with indicated oligos, serum-starved overnight. D, proliferation of H358-TwistER cells before EMT in the absence of serum after transfection with indicated siRNAs. IP, immunoprecipitation; WCL, whole-cell lysates; IgG, immunoglobulin G; NT, untreated. Megan B. Salt et al. Cancer Discovery 2014;4: ©2014 by American Association for Cancer Research

Download ppt "Knockdown of ERBB3, NRG1, or ERBB2 in H358-TwistER cells reduces basal PI3K–AKT signaling and ablates serum-independent proliferation before EMT. A and."

Similar presentations

SCLCs and LCNECs are sensitive to PARP inhibition in vitro.

SCLCs and LCNECs are sensitive to PARP inhibition in vitro.
CDC20 interacts with conductin and induces its proteosomal degradation

CDC20 interacts with conductin and induces its proteosomal degradation
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial- Mesenchymal Transition in Gastric Cancer Cells  Yu Cheng, Yongxi Song, Jinglei.

The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial- Mesenchymal Transition in Gastric Cancer Cells  Yu Cheng, Yongxi Song, Jinglei.
MEL23 and MEL24 inhibit Mdm2 and p53 ubiquitination in cells.

MEL23 and MEL24 inhibit Mdm2 and p53 ubiquitination in cells.
DEAR1 binds to SMAD3 and induces SMAD3 ubiquitination.

DEAR1 binds to SMAD3 and induces SMAD3 ubiquitination.
Knock-down of endogenous PINK1 abrogates Parkin Ser65 phosphorylation.

Knock-down of endogenous PINK1 abrogates Parkin Ser65 phosphorylation.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
NRP2 represses IGF-IR expression and signaling.

NRP2 represses IGF-IR expression and signaling.
PDK1 regulates PLK1 in vivo and in vitro.

PDK1 regulates PLK1 in vivo and in vitro.
Phospho-Twist1–induced TGF-β2 acts as an essential mediator of signaling cross-talk between TGF-βR/Smad2 and PI3K/Akt axes. Phospho-Twist1–induced TGF-β2.

Phospho-Twist1–induced TGF-β2 acts as an essential mediator of signaling cross-talk between TGF-βR/Smad2 and PI3K/Akt axes. Phospho-Twist1–induced TGF-β2.
A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.

A20 inhibits caspase-8 cleavage and TRAIL-induced apoptosis.
ABIN-1 inhibits IL-17–dependent NF-κB activation.

ABIN-1 inhibits IL-17–dependent NF-κB activation.
PKA interacts with HIF-1α.

PKA interacts with HIF-1α.
Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.

Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation. Downregulation of SPRY4 expression is associated with FGFR1–FRS2 activation.
PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,

PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,
Expression of SYCE2 inhibits the interaction of HP1α with H3K9me3.

Expression of SYCE2 inhibits the interaction of HP1α with H3K9me3.
Signaling induced by BRAF L597R and L597S is sensitive to BRAF and MEK inhibitors. Signaling induced by BRAF L597R and L597S is sensitive to BRAF and MEK.

Signaling induced by BRAF L597R and L597S is sensitive to BRAF and MEK inhibitors. Signaling induced by BRAF L597R and L597S is sensitive to BRAF and MEK.
Role of HER2 in mediating acquired resistance to EGFR inhibition.

Role of HER2 in mediating acquired resistance to EGFR inhibition.
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.

A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. (A) Western.

ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. ONC201 activates the ATF4 pathway through the eIF2α kinases HRI and PKR. (A) Western.

Similar presentations

Ads by Google